Cancer - Press Review (April 27, 2013) – Revue de presse (27 avril 2013)

[SMW]

Cancer – Press Review – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press Review (April 27, 2013) – Revue de presse (27 avril 2013)

Cancer Physicians Attack High Drug Costs
With the cost of some lifesaving cancer drugs exceeding $100,000 a
year, more than 100 influential cancer specialists from around the
world have taken the unusual step of banding together in hopes of
persuading some leading pharmaceutical companies to bring prices down.
By Andrew Pollack. In The New York Times
http://www.nytimes.com/2013/04/26/business/cancer-physicians-attack-high-drug-costs.html?pagewanted=all&_r=0

Skin Cancer Linked to Higher Risk of Other Cancers
There’s another reason for those at risk of skin cancer to stay
vigilant about protecting their health. Men and women with a history
of non-melanoma skin cancer are at a higher risk of developing breast
and lung cancers in addition to melanoma, compared to people without a
skin cancer history
By Alexandra Sifferlin. In TIME
http://healthland.time.com/2013/04/25/skin-cancer-linked-to-a-higher-risk-of-other-cancers/?iid=tsmodule

Cancer survival rates improve but most people remain financially
exposed
Medical advance means more people diagnosed with cancer are surviving
for longer, according to new figures from the Office for National
Statistics (ONS), but relatively few people have any financial
protection in place against the risk of living with reduced earning
power.
By Ian Cowie. In Telegraph.co.uk (blog)
http://blogs.telegraph.co.uk/finance/ianmcowie/100024109/cancer-survival-rates-improve-but-most-people-remain-financially-exposed/

Chernobyl Follow-Up Study Finds High Survival Rate Among Young Thyroid
Cancer Patients
More than a quarter of a century after the Chernobyl nuclear disaster,
many children and teenagers who developed thyroid cancer due to
radiation are in complete or near remission, according to a recent
study accepted for publication in The Endocrine Society's Journal of
Clinical Endocrinology & Metabolism (JCEM).
In Science Daily (press release)
http://www.sciencedaily.com/releases/2013/04/130424132630.htm

Adrenalectomy for Metastases Benefits Renal-Cancer Patients
Surgical removal of adrenal metastases can offer long-term survival to
selected cancer patients — most notably those with renal-cell
carcinoma — the results of a large multicenter study indicate.
By Miriam E. Tucker. In Medscape
http://www.medscape.com/viewarticle/803106


Les centres d'essais cliniques précoces contre le cancer
Comme tous les médicaments, les traitements contre le cancer doivent
être évalués avoir de recevoir leur autorisation de mise sur le
marché. Mais très souvent le temps presse pour les patients qui
souhaitent bénéficier des techniques les plus avancées. C'est ainsi
que sont nés les centres d'essais cliniques précoces.
Dans France Info
http://www.franceinfo.fr/sciences-sante/info-sante/les-centres-d-essais-cliniques-precoces-contre-le-cancer-963599-2013-04-24

Traitements ciblés contre le cancer: l'eldorado risqué des grands
labos
Proposer à des millions de patients des "traitements ciblés" en
fonction de mutations génétiques retrouvées dans leur cancer, est
devenu l'axe essentiel de la recherche pour les grands laboratoires,
pari qui n'est pas sans risque vu le temps et les sommes colossales
investis.
Par Olivier Thibault. Sur TV5
http://www.tv5.org/cms/chaine-francophone/info/p-1911-Traitements-cibles-contre-le-cancer-l-eldorado-risque-des-grands-labos.htm?&rub=15&xml=newsmlmmd.0dbe642021e32935464f366ab44af89d.121.xml









Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com













Marc Lacroix-Corman – InTextoResearch – Baelen (04/2013)